Ubiquitin B in cervical cancer: Critical for the maintenance of cancer stem-like cell characters

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Tian, Yuan ^a   Ding, Wencheng ^a   Wang, Yingying ^b   Ji, Teng ^a   Sun, Shujuan ^a   Mo, Qingqing ^a   Chen, Pingbo ^a   Fang, Yong ^a   Liu, Jia ^a   Wang, Beibei ^a   Zhou, Jianfeng ^a   Ma, Ding ^a   Wu, Peng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRICHOSTATIN A; UBIQUITIN; UBIQUITIN B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GENE; TUMOR SPHEROID; UBB GENE; UPREGULATION; UTERINE CERVIX CANCER;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MICE; NEOPLASTIC STEM CELLS; RNA, SMALL INTERFERING; SPHEROIDS, CELLULAR; UBIQUITIN; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84893167233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084457     Document Type: Article

References (18)

1. Peralta-Zaragoza O, Bermúdez-Morales VH, Pérez-Plasencia C, Salazar-León J, Gómez-Cerón C et al. (2012) Targeted treatments for cervical cancer: a review. Onco Targets Ther 5: 315-328. PubMed: 23144564.
2. Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA (2012) Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases. Vaccine 30 Suppl 5: F1-F11. doi:10.1016/j.vaccine.2011.10.108. PubMed: 23199951.
3. Cadron I, Van Gorp T, Amant F, Leunen K, Neven P et al. (2007) Chemotherapy for recurrent cervical cancer. Gynecol Oncol 107: S113-S118. doi:10.1016/j.ygyno.2007.07.004. PubMed: 17804044. (Pubitemid 47496062)
4. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768. doi:10.1038/nrc2499. PubMed: 18784658.
5. Todaro M, Lombardo Y, Stassi G (2010) Evidences of cervical cancer stem cells derived from established cell lines. Cell Cycle 9: 1238-1239. doi:10.4161/cc.9.7.11194. PubMed: 20404528.
6. Wu P, Tian Y, Chen G, Wang B, Gui L et al. (2010) Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. Cell Death Differ 17: 109-118. doi:10.1038/cdd.2009.142. PubMed: 19798105.
7. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLOS Biol 8: e1000412. PubMed: 22424462223904252135061720613859.
8. Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM et al. (2010) Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst 102: 1637-1652. doi:10.1093/jnci/ djq361. PubMed: 20935265.
9. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988. doi:10.1073/pnas.0530291100. PubMed: 12629218. (Pubitemid 36418143)
10. Rizzo S, Hersey JM, Mellor P, Dai W, Santos-Silva A et al. (2011) Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther 10: 325-335. doi:10.1158/1535-7163.MCT-10- 0788. PubMed: 21216927.
11. Yu F, Yao H, Zhu P, Zhang X, Pan Q et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123. doi:10.1016/j.cell.2007.10.054. PubMed: 18083101. (Pubitemid 350235025)
12. Xu WS, Parmigiani RB, Marks PA (2007) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26: 5541-5552. doi:10.1038/sj.onc. 1210620. PubMed: 17694093. (Pubitemid 47255934)
13. Kim HJ, Bae SC (2011) Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3: 166-179. PubMed: 21416059.
14. Hemmings C (2010) The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis. Pathology 42: 105-112. doi:10.3109/00313020903488773. PubMed: 20085510.
15. Nenoi M (1992) Induced accumulation of polyubiquitin gene transcripts in HeLa cells after UV-irradiation and TPA-treatment. Int J Radiat Biol 61: 205-211. doi:10.1080/09553009214550831. PubMed: 1351908.
16. Delic J, Morange M, Magdelenat H (1993) Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis. Mol Cell Biol 13: 4875-4883. PubMed: 8393139. (Pubitemid 23220393)
17. Finch JS, St John T, Krieg P, Bonham K, Smith HT et al. (1992) Overexpression of three ubiquitin genes in mouse epidermal tumors is associated with enhanced cellular proliferation and stress. Cell Growth Differ 3: 269-278. PubMed: 1321656. Available online at: PubMed: 1321656
18. Kenward N, Hope J, Landon M, Mayer RJ (1994) Expression of polyubiquitin and heat-shock protein 70 genes increases in the later stages of disease progression in scrapie-infected mouse brain. J Neurochem 62: 1870-1877. PubMed: 7512619. (Pubitemid 24121881)